Orthostatic Hypotension in Parkinson Disease: How Much You Fall or How Low You Go?

Orthostatic hypotension (OH) is frequent in patients with Parkinson's disease (PD) and can occur with or without symptoms. Pharmacological treatments are effective, but often exacerbate supine hypertension. Guidelines exist for the diagnosis, but not for the treatment of OH. We examined the relationship between blood pressure (BP) and symptoms in a cohort of PD patients with the goal of identifying a hemodynamic target to guide treatment. We measured BP supine and upright (tilt or active standing) and identified the presence or absence of symptomatic OH by using a validated patient‐reported outcome questionnaire in 210 patients with PD. We evaluated the usefulness of the 20/10 and 30/15 mmHg diagnostic criteria (systolic/diastolic) to identify symptomatic OH. Fifty percent of the PD patient cohort met criteria for the 20/10 fall and 30% for the 30/15 BP fall. Among the patients who met either OH criteria, the percentage of those with symptoms was small (33% of those with 20/10 and 44% of those with 30/15 mmHg; 16% and 13%, respectively, overall). Symptomatic OH was associated with an upright mean BP below 75 mmHg. A mean standing BP <75 mmHg had a sensitivity of 97% and a specificity of 98% for detecting symptomatic OH. Although the prevalence of OH in PD is high, not all patients have symptoms of organ hypoperfusion. A mean standing BP below 75 mmHg appears to be a useful benchmark when deciding whether the benefits of initiating pharmacological treatment of OH outweigh the risks of exacerbating supine hypertension. © 2015 International Parkinson and Movement Disorder Society

[1]  D. Calne,et al.  Hypotension Caused by L-Dopa , 1970, British medical journal.

[2]  G. Guyatt,et al.  Midodrine for orthostatic hypotension and recurrent reflex syncope , 2014, Neurology.

[3]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[4]  E. Casiglia,et al.  Arterial hypertension, a tricky side of Parkinson’s disease: physiopathology and therapeutic features , 2013, Neurological Sciences.

[5]  D. Goldstein,et al.  Association Between Supine Hypertension and Orthostatic Hypotension in Autonomic Failure , 2003, Hypertension.

[6]  R. Freeman,et al.  The Orthostatic Hypotension Questionnaire (OHQ): validation of a novel symptom assessment scale , 2012, Clinical Autonomic Research.

[7]  A. Maillet,et al.  Enhanced flow-dependent vasodilatation after bed rest, a possible mechanism for orthostatic intolerance in humans , 2001, European Journal of Applied Physiology.

[8]  J. P. Henry,et al.  Factors maintaining cerebral circulation during gravitational stress. , 1951, The Journal of clinical investigation.

[9]  C. Clarke,et al.  Systematic review of levodopa dose equivalency reporting in Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.

[10]  Arthur A M Wilde,et al.  Symptoms and signs of syncope: a review of the link between physiology and clinical clues. , 2009, Brain : a journal of neurology.

[11]  C. Mathias,et al.  Are current recommendations to diagnose orthostatic hypotension in Parkinson's disease satisfactory? , 2009, Movement disorders : official journal of the Movement Disorder Society.

[12]  Roger Hainsworth,et al.  Pathophysiology of syncope , 2004, Clinical Autonomic Research.

[13]  Daniel W. Jones,et al.  Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. , 2005, Hypertension.

[14]  R. Freeman,et al.  Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group. , 1997, JAMA.

[15]  D. Katz,et al.  Treating orthostatic hypotension in patients with Parkinson's disease and atypical Parkinsonism improves function. , 2012, Journal of Parkinson's disease.

[16]  A. Kupsch,et al.  Normal cerebral hemodynamic response to orthostasis in Parkinson's disease. , 2002, Parkinsonism & related disorders.

[17]  M. Vidailhet,et al.  Myoclonus or tremor in orthostatism: An under‐recognized cause of unsteadiness in Parkinson's disease , 2007, Movement disorders : official journal of the Movement Disorder Society.

[18]  Y. Ben-Shlomo,et al.  The influence of age and gender on motor and non-motor features of early Parkinson's disease: initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort. , 2014, Parkinsonism & Related Disorders.

[19]  D. Foley,et al.  Orthostatic hypotension predicts mortality in elderly men: the Honolulu Heart Program. , 1998, Circulation.

[20]  D. Goldstein,et al.  Prevalence of orthostatic hypotension in Parkinson's disease: a systematic review and meta-analysis. , 2011, Parkinsonism & related disorders.

[21]  L. Rumbach,et al.  Side-effects of L-dopa on venous tone in Parkinson's disease: a leg-weighing assessment. , 2006, Clinical science.

[22]  L. Rumbach,et al.  Impaired cardiovascular autonomic control in newly and long-term-treated patients with Parkinson's disease: involvement of l-dopa therapy , 2004, Autonomic Neuroscience.

[23]  D. Horowitz,et al.  Autoregulatory cerebral vasodilation occurs during orthostatic hypotension in patients with primary autonomic failure , 2001, Clinical Autonomic Research.

[24]  H Kaufmann,et al.  Consensus statement on the definition of orthostatic hypotension, pure autonomic failure and multiple system atrophy , 1996, Clinical Autonomic Research.

[25]  J. Jankovic,et al.  The prevalence of symptomatic orthostatic hypotension in patients with Parkinson's disease and atypical parkinsonism. , 2011, Parkinsonism & related disorders.

[26]  A. Alshekhlee,et al.  Hypotension unawareness in profound orthostatic hypotension. , 2009, The American journal of medicine.

[27]  J. Jankovic,et al.  Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine. , 1993, The American journal of medicine.

[28]  R. Hainsworth,et al.  Effects of moderate exercise training on plasma volume, baroreceptor sensitivity and orthostatic tolerance in healthy subjects , 1999, Experimental physiology.

[29]  D. Goldstein,et al.  Orthostatic hypotension from sympathetic denervation in Parkinson’s disease , 2002, Neurology.

[30]  Viv Bewick,et al.  Statistics review 13: Receiver operating characteristic curves , 2004, Critical care.

[31]  H. Kaufmann,et al.  Is ambulatory blood pressure monitoring useful in patients with chronic autonomic failure? , 2014, Clinical Autonomic Research.

[32]  J. Zarranz,et al.  Nocturnal hypertension and dysautonomia in patients with Parkinson’s disease: are they related? , 2013, Journal of Neurology.

[33]  Jens Jordan,et al.  Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome , 2011, Clinical Autonomic Research.

[34]  R. Freeman,et al.  Droxidopa for neurogenic orthostatic hypotension randomized, placebo-controlled, phase 3 trial , 2014 .

[35]  H. Kaufmann,et al.  Autonomic failure in neurodegenerative disorders. , 2003, Seminars in neurology.

[36]  L. Shaffer,et al.  Orthostatic Hypotension in Patients with Dementia: Clinical Features and Response to Treatment , 2013, Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.